Cartesian Therapeutics (RNAC) Enterprise Value (2015 - 2026)
Cartesian Therapeutics (RNAC) posted quarterly Enterprise Value of -$1.7 million for Q1 2026, up 99.06% year-over-year from -$854023.2 in Q1 2025, and up 98.64% quarter-over-quarter from -$125.1 million in Q4 2025.
Cartesian Therapeutics (RNAC) Enterprise Value (2015 - 2026) Analysis & Trends
Cartesian Therapeutics (RNAC) has reported Enterprise Value for 12 consecutive years, with -$1.7 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Enterprise Value rose 99.06% year-over-year to -$1.7 million; the TTM figure through Mar 2026 stood at -$1.7 million (up 99.06% YoY), while the FY2025 annual figure was -$125.1 million, up 41.14% from the prior year.
- Enterprise Value improved to -$1.7 million in Q1 2026 per RNAC's latest filing, from -$125.1 million in the prior quarter.
- Across five years, Enterprise Value topped out at -$1.7 million in Q2 2025 and bottomed at -$219.2 million in Q3 2024.
- Historically, Enterprise Value has averaged -$109.9 million across 5 years, with a median of -$117.4 million in 2022.
- Annual changes were most pronounced in 2024 — Enterprise Value plunged 176.44% — and 2025, when it jumped 99.22%.
- Cartesian Therapeutics' Enterprise Value stood at -$134.6 million in 2022, then jumped by 42.86% to -$76.9 million in 2023, then plunged by 176.44% to -$212.6 million in 2024, then soared by 41.14% to -$125.1 million in 2025, then surged by 98.64% to -$1.7 million in 2026.
- Business Quant data shows RNAC's Enterprise Value at -$1.7 million in Q1 2026, -$125.1 million in Q4 2025, and -$1.7 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Enterprise Value (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | -7.85 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | -7.99 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | -5.18 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | -3.94 Bn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | -5.10 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | -8.46 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 2.12 Bn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | -3.31 Bn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | -1.16 Bn |
| 10 | Cartesian Therapeutics | 265.54 Mn | 265.54 Mn | - | -147.61 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -147.61 Mn |
| Mar 31, 2026 | -1.70 Mn |
| Dec 31, 2025 | -125.14 Mn |
| Sep 30, 2025 | -1.70 Mn |
| Jun 30, 2025 | -1.70 Mn |
| Mar 31, 2025 | -180.43 Mn |
| Dec 31, 2024 | -212.61 Mn |
| Sep 30, 2024 | -219.20 Mn |
| Jun 30, 2024 | -87.23 Mn |
| Mar 31, 2024 | -103.42 Mn |
| Dec 31, 2023 | -76.91 Mn |
| Sep 30, 2023 | -79.60 Mn |
| Jun 30, 2023 | -112.03 Mn |
| Mar 31, 2023 | -125.93 Mn |
| Dec 31, 2022 | -134.60 Mn |
| Sep 30, 2022 | -146.44 Mn |
| Jun 30, 2022 | -142.06 Mn |
| Mar 31, 2022 | -117.43 Mn |
| Dec 31, 2021 | -128.06 Mn |
| Sep 30, 2021 | -138.66 Mn |